| Dr Jae In Lee, MD | |
|
19450 Deerfield Ave Ste 100, Leesburg, VA 20176-6821 | |
| (571) 350-3668 | |
| (703) 729-2689 |
| Full Name | Dr Jae In Lee |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 12 Years |
| Location | 19450 Deerfield Ave Ste 100, Leesburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083971410 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Fauquier Hospital | Warrenton, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
Antibodies produced during a previous case of COVID-19 or vaccine-induced immunity are targeted towards S protein, where the neutralizing antibodies attach to the Spike RBD domain. Some of the variants have mutations in their RBD domain, causing resistance to the neutralizing antibodies. However, the effect of these mutations on the affinity and kinetics of the binding of Spike RBD to ACE2 is not clear. A new study has been published on the bioRxiv* preprint server, which deals with the study of affinity and kinetic analysis of the interface between Spike RBD and ACE2 at physiological temperatures.
Freedom from disability is one of the most important patient-centered outcomes after surgery, but there is currently no validated instrument to measure postoperative disability.
Researchers report that two "new" equations may accurately measure kidney function in elderly individuals with nonsevere kidney disease.
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
› Verified 9 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
Antibodies produced during a previous case of COVID-19 or vaccine-induced immunity are targeted towards S protein, where the neutralizing antibodies attach to the Spike RBD domain. Some of the variants have mutations in their RBD domain, causing resistance to the neutralizing antibodies. However, the effect of these mutations on the affinity and kinetics of the binding of Spike RBD to ACE2 is not clear. A new study has been published on the bioRxiv* preprint server, which deals with the study of affinity and kinetic analysis of the interface between Spike RBD and ACE2 at physiological temperatures.
Freedom from disability is one of the most important patient-centered outcomes after surgery, but there is currently no validated instrument to measure postoperative disability.
Researchers report that two "new" equations may accurately measure kidney function in elderly individuals with nonsevere kidney disease.
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jae In Lee, MD 2901 Telestar Ct Ste 300, Falls Church, VA 22042-1263 Ph: (703) 591-1688 | Dr Jae In Lee, MD 19450 Deerfield Ave Ste 100, Leesburg, VA 20176-6821 Ph: (571) 350-3668 |
News Archive
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
Antibodies produced during a previous case of COVID-19 or vaccine-induced immunity are targeted towards S protein, where the neutralizing antibodies attach to the Spike RBD domain. Some of the variants have mutations in their RBD domain, causing resistance to the neutralizing antibodies. However, the effect of these mutations on the affinity and kinetics of the binding of Spike RBD to ACE2 is not clear. A new study has been published on the bioRxiv* preprint server, which deals with the study of affinity and kinetic analysis of the interface between Spike RBD and ACE2 at physiological temperatures.
Freedom from disability is one of the most important patient-centered outcomes after surgery, but there is currently no validated instrument to measure postoperative disability.
Researchers report that two "new" equations may accurately measure kidney function in elderly individuals with nonsevere kidney disease.
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
› Verified 9 days ago
Munira Dabhiya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44045 Riverside Pkwy, Leesburg, VA 20176 Phone: 703-858-6000 Fax: 703-858-6900 | |
Mr. Warren Joseph Marion, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 38483 Forest Mills Rd, Leesburg, VA 20175 Phone: 540-338-3447 Fax: 540-338-3447 | |
Dr. Sandhya Chanda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19450 Deerfield Ave, Suite 400, Leesburg, VA 20176 Phone: 571-223-5723 Fax: 571-209-1848 | |
Ann I Ma, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 224d Cornwall St Nw, Suite 207, Leesburg, VA 20176 Phone: 703-771-9001 Fax: 703-771-9076 | |
Yaser Cheema, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19450 Deerfield Avenue, Suite 325, Leesburg, VA 20176 Phone: 571-252-8119 Fax: 800-735-1643 | |
Shruti Rakesh Tiwari, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44035 Riverside Pkwy Ste 300, Leesburg, VA 20176 Phone: 703-208-3155 Fax: 703-724-7503 |